CN101223133B - 双(硫代酰肼酰胺)盐的合成 - Google Patents

双(硫代酰肼酰胺)盐的合成 Download PDF

Info

Publication number
CN101223133B
CN101223133B CN2006800170928A CN200680017092A CN101223133B CN 101223133 B CN101223133 B CN 101223133B CN 2006800170928 A CN2006800170928 A CN 2006800170928A CN 200680017092 A CN200680017092 A CN 200680017092A CN 101223133 B CN101223133 B CN 101223133B
Authority
CN
China
Prior art keywords
methyl
alkali
organic solvent
phenyl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2006800170928A
Other languages
English (en)
Chinese (zh)
Other versions
CN101223133A (zh
Inventor
陈寿军
夏志强
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synta Phamaceuticals Corp
Original Assignee
Synta Phamaceuticals Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synta Phamaceuticals Corp filed Critical Synta Phamaceuticals Corp
Publication of CN101223133A publication Critical patent/CN101223133A/zh
Application granted granted Critical
Publication of CN101223133B publication Critical patent/CN101223133B/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00Thiocarboxylic acids
    • C07C327/38Amides of thiocarboxylic acids
    • C07C327/56Amides of thiocarboxylic acids having nitrogen atoms of thiocarboxamide groups further bound to another hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/04Systems containing only non-condensed rings with a four-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN2006800170928A 2005-05-16 2006-05-11 双(硫代酰肼酰胺)盐的合成 Expired - Fee Related CN101223133B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68126305P 2005-05-16 2005-05-16
US60/681,263 2005-05-16
PCT/US2006/018653 WO2006124736A2 (en) 2005-05-16 2006-05-11 Synthesis of bis(thio-hydrazide amide) salts

Publications (2)

Publication Number Publication Date
CN101223133A CN101223133A (zh) 2008-07-16
CN101223133B true CN101223133B (zh) 2012-02-29

Family

ID=37057197

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2006800170928A Expired - Fee Related CN101223133B (zh) 2005-05-16 2006-05-11 双(硫代酰肼酰胺)盐的合成

Country Status (16)

Country Link
US (1) US7709683B2 (https=)
EP (1) EP1888520A2 (https=)
JP (1) JP2008540658A (https=)
KR (1) KR20080008399A (https=)
CN (1) CN101223133B (https=)
AU (1) AU2006247470B2 (https=)
BR (1) BRPI0611262A2 (https=)
CA (1) CA2607890A1 (https=)
IL (1) IL187056A (https=)
MX (1) MX2007014314A (https=)
NO (1) NO20075707L (https=)
NZ (1) NZ563124A (https=)
RU (1) RU2407734C2 (https=)
TW (1) TWI387579B (https=)
WO (1) WO2006124736A2 (https=)
ZA (1) ZA200709395B (https=)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI332943B (en) 2001-07-10 2010-11-11 Synta Pharmaceuticals Corp Taxol enhancer compounds
TWI252847B (en) * 2001-07-10 2006-04-11 Synta Pharmaceuticals Corp Synthesis of taxol enhancers
TWI297335B (en) 2001-07-10 2008-06-01 Synta Pharmaceuticals Corp Taxol enhancer compounds
TWI330079B (en) * 2003-01-15 2010-09-11 Synta Pharmaceuticals Corp Treatment for cancers
PL1781604T3 (pl) 2004-06-23 2014-01-31 Synta Pharmaceuticals Corp Sole bis(tiohydrazydoamidu) do leczenia nowotworów
AU2005306471B2 (en) * 2004-11-19 2009-12-17 Synta Pharmaceuticals Corp. Bis(thio-hydrazide amides) for increasing Hsp70 expression
US20090042991A1 (en) * 2005-04-15 2009-02-12 James Barsoum Methods of increasing natural killer cell activity for therapy
MX2007012688A (es) 2005-04-15 2008-03-14 Synta Pharmaceuticals Corp Terapia de combinacion para el cancer con compuestos de bis(tiohidrazida) amida.
US7678832B2 (en) * 2005-08-16 2010-03-16 Synta Pharmaceuticals Corp. Bis(thio-hydrazide amide) formulation
WO2008024299A2 (en) * 2006-08-21 2008-02-28 Synta Pharmaceuticals Corp. Combination with bis(thiohydrazide amides) for treating cancer
RU2475478C2 (ru) 2006-08-21 2013-02-20 Синта Фармасьютиклз Корп. Соединения для лечения пролиферативных расстройств
AU2007288340A1 (en) * 2006-08-21 2008-02-28 Synta Pharmaceuticals Corp. Bis (thiohydrazide amides) for treating melanoma
EP2063878A2 (en) * 2006-08-21 2009-06-03 Synta Pharmaceuticals Corporation Bis(thiohydrazide amides) for use in preventing or delaying the recurrence of melanoma
JP2010502616A (ja) * 2006-08-31 2010-01-28 シンタ ファーマシューティカルズ コーポレーション 癌を治療するためのビス(チオヒドラジドアミド)の組み合わせ
US9498528B2 (en) * 2006-09-13 2016-11-22 Genzyme Corporation Treatment of multiple sclerosis (MS)
WO2008033494A2 (en) 2006-09-15 2008-03-20 Synta Pharmaceuticals Corp. Purification of bis(thiohydrazide amides)
WO2009064374A2 (en) 2007-11-09 2009-05-22 Synta Pharmaceuticals Corp. Oral formulations of bis(thiohydrazide amides)
US8581004B2 (en) 2008-02-21 2013-11-12 Synta Pharmaceuticals Corp. Compounds for treating proliferative disorders
US8633323B2 (en) * 2008-03-31 2014-01-21 Synta Pharmaceuticals Corp. Process for preparing bis(thiohydrazide amides)
MX2011004114A (es) 2008-10-22 2011-08-15 Synta Pharmaceuticals Corp Complejos de metales de transicion de un compuesto bis (tiohidrazida amida).
NZ592400A (en) 2008-10-22 2013-09-27 Synta Pharmaceuticals Corp Transition metal complexes of bis[thiohydrazide amide] compounds
US8525776B2 (en) * 2008-10-27 2013-09-03 Lenovo (Singapore) Pte. Ltd Techniques for controlling operation of a device with a virtual touchscreen
EP2370402A2 (en) 2008-12-01 2011-10-05 Synta Pharmaceuticals Corp. Compounds for treating proliferative disorders
WO2011069159A2 (en) 2009-12-04 2011-06-09 Synta Pharmaceuticals Corp. Bis[thiohydrazide amide] compounds for treating leukemia
US8815945B2 (en) 2010-04-20 2014-08-26 Masazumi Nagai Use of bis [thiohydrazide amide] compounds such as elesclomol for treating cancers

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1553894A (zh) * 2001-07-10 2004-12-08 ����ҽҩƷ���޹�˾ 紫杉醇增强化合物

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2097737A5 (en) 1970-07-14 1972-03-03 Berlin Chemie Veb Virustatic 4-substd 1-acylthiosemicarbazides -from carboxylic acid - hydrazide and isothiocyanates or from carboxylic acid chloride and 4-
DE2037257A1 (en) 1970-07-28 1972-02-03 Farbwerke Hoechst AG, vorm. Meister Lucius & Brüning, 6000 Frankfurt Poly-(5-amino-1,3,4-thiadiazol-2-yl) derivs prepn - intermediates for drug and polymer prodn
US4012360A (en) 1973-12-03 1977-03-15 Ciba-Geigy Corporation Bis-salicyloyl-dicarboxylic acid dihydrazides as stabilizers for polyolefines
JPS5091056A (https=) 1973-12-17 1975-07-21
US6013836A (en) 1992-02-28 2000-01-11 Rohm And Haas Company Insecticidal N'-substituted-N,N'-disubstitutedhydrazines
FR2697752B1 (fr) 1992-11-10 1995-04-14 Rhone Poulenc Rorer Sa Compositions antitumorales contenant des dérivés du taxane.
ATE184613T1 (de) 1995-09-22 1999-10-15 Novo Nordisk As Varianten des grünen fluoreszenzproteins, gfp
US6235787B1 (en) 1997-06-30 2001-05-22 Hoffmann-La Roche Inc. Hydrazine derivatives
GB9727524D0 (en) 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Synergistic antitumor composition containing a biologically active ureido compound
TW479053B (en) 1998-10-19 2002-03-11 Agro Kanesho Co Ltd Hydrazineoxoacetamide derivatives and pesticides
ES2161594B1 (es) 1998-12-17 2003-04-01 Servier Lab Nuevos derivados de la hidrazida, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
US6322303B1 (en) 2000-05-12 2001-11-27 David M. John Dunnage bag and method of making same
EP1164126A1 (de) 2000-06-16 2001-12-19 Basf Aktiengesellschaft Salicylsäurehydrazid-Derivate, Verfahren und Zwischenprodukte zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung zur Bekämpfung von Schadpilzen
US6365745B1 (en) 2000-07-14 2002-04-02 Sumika Fine Chemicals Co., Ltd. Method for producing hydrazine derivative
US6656971B2 (en) 2001-01-25 2003-12-02 Guilford Pharmaceuticals Inc. Trisubstituted carbocyclic cyclophilin binding compounds and their use
US6602907B1 (en) 2001-06-08 2003-08-05 University Of Central Florida Treatment of breast cancer
TWI252847B (en) * 2001-07-10 2006-04-11 Synta Pharmaceuticals Corp Synthesis of taxol enhancers
TWI332943B (en) 2001-07-10 2010-11-11 Synta Pharmaceuticals Corp Taxol enhancer compounds
US6924312B2 (en) * 2001-07-10 2005-08-02 Synta Pharmaceuticals Corp. Taxol enhancer compounds
TW200408407A (en) * 2001-11-30 2004-06-01 Dana Farber Cancer Inst Inc Methods and compositions for modulating the immune system and uses thereof
TWI330079B (en) 2003-01-15 2010-09-11 Synta Pharmaceuticals Corp Treatment for cancers
PL1781604T3 (pl) * 2004-06-23 2014-01-31 Synta Pharmaceuticals Corp Sole bis(tiohydrazydoamidu) do leczenia nowotworów
WO2006033913A2 (en) 2004-09-16 2006-03-30 Synta Pharmaceuticals Corp. Bis (thio-hydrazide amides) for treament of hyperplasia
AU2005306471B2 (en) * 2004-11-19 2009-12-17 Synta Pharmaceuticals Corp. Bis(thio-hydrazide amides) for increasing Hsp70 expression
WO2006113493A2 (en) 2005-04-15 2006-10-26 Synta Pharmaceuticals Corp. Methods of determining cancer prognosis via natural killer cell activity
US20090042991A1 (en) 2005-04-15 2009-02-12 James Barsoum Methods of increasing natural killer cell activity for therapy
MX2007012688A (es) 2005-04-15 2008-03-14 Synta Pharmaceuticals Corp Terapia de combinacion para el cancer con compuestos de bis(tiohidrazida) amida.
US7678832B2 (en) * 2005-08-16 2010-03-16 Synta Pharmaceuticals Corp. Bis(thio-hydrazide amide) formulation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1553894A (zh) * 2001-07-10 2004-12-08 ����ҽҩƷ���޹�˾ 紫杉醇增强化合物

Also Published As

Publication number Publication date
WO2006124736A2 (en) 2006-11-23
IL187056A0 (en) 2008-02-09
RU2007144216A (ru) 2009-06-27
WO2006124736A3 (en) 2007-03-29
NZ563124A (en) 2010-12-24
IL187056A (en) 2013-10-31
JP2008540658A (ja) 2008-11-20
ZA200709395B (en) 2008-10-29
AU2006247470A1 (en) 2006-11-23
US7709683B2 (en) 2010-05-04
TWI387579B (zh) 2013-03-01
US20060270873A1 (en) 2006-11-30
TW200722411A (en) 2007-06-16
CA2607890A1 (en) 2006-11-23
EP1888520A2 (en) 2008-02-20
NO20075707L (no) 2007-12-11
MX2007014314A (es) 2008-02-11
KR20080008399A (ko) 2008-01-23
RU2407734C2 (ru) 2010-12-27
AU2006247470B2 (en) 2010-04-01
CN101223133A (zh) 2008-07-16
BRPI0611262A2 (pt) 2010-08-24

Similar Documents

Publication Publication Date Title
CN101223133B (zh) 双(硫代酰肼酰胺)盐的合成
JP2021524838A5 (https=)
CN110041327B (zh) 吡啶酮衍生物、其组合物及作为抗流感病毒药物的应用
CN109563515A (zh) 化合物和调节rna功能的方法
TW201726599A (zh) 陽離子性脂質
CN106928206A (zh) 醛基类化合物及其制法和用途
JP2018076234A (ja) ピラゾロ[1,5−a]ピリミジン化合物
WO2023036311A1 (zh) 可离子化脂质体、其制备及在基因递送中的应用
CN110105348A (zh) 新型迈克尔受体类肠病毒71型抑制剂的制备及用途
JP2002517390A (ja) Hivインテグラーゼ阻害薬
CN101970399A (zh) 组蛋白脱乙酰酶抑制剂
JP2022530546A (ja) カスパーゼ阻害剤のプロドラッグ
WO2009073147A2 (en) Process for preparing bis(thiohydrazide amides)
RU2018125748A (ru) Пролекарство на основе уридинфосфорамида, способ его получения и его применения в медицине
JP2009526773A (ja) 細菌感染症治療のためのスルホンアミド誘導体
CN111153952B (zh) N-叠氮基乙酰-d-甘露糖胺衍生物及其制备方法和在检测酯酶中的应用
JP7716147B2 (ja) 置換されたイソインドリン-1,3-ジオン類pde4阻害剤及びその薬物応用
CN104961670B (zh) 一种n,o‑双取代的酮亚胺衍生物的制备方法
CN108558869B (zh) 用于治疗肝癌的化合物及其制剂
CN121342810A (zh) 一种水飞蓟宾衍生物、其制备方法及应用
CN121362190A (zh) 一种氮-(1-(9h-嘌呤-6-基)哌啶-4-基)苯甲酰胺类化合物、含其的药物组合物及其应用
KR20070107119A (ko) 일반적으로 세포독성, 특히 아폽토시스와 관련된 유해상태의 예방 및 치료용 글루타티온-s-트랜스퍼라제 및nadph 퀴논 옥시도-리덕타제의 유도인자인[1,2,4]-디티아졸린 및 -디티아졸리딘 유도체
CN114533891A (zh) 一种靶向无痕释放药物缀合物及其制备方法与应用
JP2026508302A (ja) ヒドロキシアルキルおよびメトキシアルキルトリプタミン
TW202434597A (zh) 抑制15-pgdh的化合物及其用途

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20120229

Termination date: 20130511